PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.\', \'Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.\', \'Laboratory Leadership Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.\', \'Wisconsin Department of Health Services, Madison, Wisconsin, USA.\', \'Marshfield Clinic Research Institute, Marshfield, Wisconsin, USA.\', \'Winnebago County Health Department, Oshkosh, Wisconsin, USA.\', \'Wisconsin State Laboratory of Hygiene, Madison, Wisconsin, USA.\', \'University of Wisconsin-Oshkosh, Oshkosh, Wisconsin, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1093/cid/ciab309
?:doi
?:hasPublicationType
?:journal
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
is ?:pmid of
?:pmid
?:pmid
  • 33909068
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Performance of Repeat BinaxNOW Severe Acute Respiratory Syndrome Coronavirus 2 Antigen Testing in a Community Setting, Wisconsin, November 2020-December 2020.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all